Clonal Hematopoiesis and Acute Ischemic Stroke Outcomes

• Published in: Annals of neurology Vol. 94; no. 5; pp. 836 - 847
• Main Authors: Lee, Eung‐Joon, An, Hong Yul, Lim, Jiwoo, Park, Kyung‐Il, Choi, Su‐Yeon, Jeong, Han‐Yeong, Kang, Dong‐Wan, Yang, Wookjin, Kim, Jeong‐Min, Ko, Sang‐Bae, Lee, Seung‐Hoon, Yoon, Byung‐Woo, Koh, Youngil, Jung, Keun‐Hwa
• Format: Journal Article
• Language: English
• Published: Hoboken, USA John Wiley & Sons, Inc 01.11.2023; Wiley Subscription Services, Inc
• Subjects: Blood cancer; Deoxyribonucleic acid; DNA; Gene frequency; Gene sequencing; Genetic transformation; Hematopoiesis; Hemopoiesis; Hemorrhage; Ischemia; Neoplasms; Regression models; Statistical analysis; Stroke
• ISSN: 0364-5134; 1531-8249; 1531-8249
• DOI: 10.1002/ana.26754

Objective The effect of clonal hematopoiesis of indeterminate potential (CHIP) on the manifestation and clinical outcomes of acute ischemic stroke (AIS) has not been fully elucidated. Methods Patients with AIS were included from a prospective registry coupled with a DNA repository. Targeted next‐generation sequencing on 25 genes that are frequently mutated in hematologic neoplasms was performed. The prevalence of CHIP was compared between patients with AIS and age‐matched healthy individuals. A multivariate linear or logistic regression model was used to assess the association among CHIP and stroke severity, hemorrhagic transformation, and functional outcome at 90 days. Results In total, 380 patients with AIS (mean age = 67.2 ± 12.7 years; 41.3% women) and 446 age‐matched controls (mean age = 67.2 ± 8.7 years; 31.4% women) were analyzed. The prevalence of CHIP was significantly higher in patients with AIS than in the healthy controls (29.0 vs 22.0%, with variant allele frequencies of 1.5%, p = 0.024). PPM1D was found to be most significantly associated with incident AIS (adjusted odds ratio [aOR] = 7.85, 95% confidence interval [CI] = 1.83–33.63, p = 0.006). The presence of CHIP was significantly associated with the initial National Institutes of Health Stroke Scale (NIHSS) score (β = 1.67, p = 0.022). Furthermore, CHIP was independently associated with the occurrence of hemorrhagic transformation (65/110 clonal hematopoiesis positive [CH+] vs 56/270 CH negative [CH‐], aOR = 5.63, 95% CI = 3.24–9.77, p < 0.001) and 90‐day functional disability (72/110 [CH+] vs 99/270 [CH‐], aOR = 2.15, 95% CI = 1.20–3.88, p = 0.011). Interpretation CH was significantly associated with incident AIS. Moreover, particularly, sequence variations in PPM1D, TET2, and DNMT3A represent a new prognostic factor for AIS. ANN NEUROL 2023;94:836–847